Citius Oncology, Inc.
General ticker "CTOR" information:
- Sector: Health Care
- Industry: Drug Manufacturers - General
- Capitalization: $126.1M (TTM average)
Citius Oncology, Inc. does not follow the US Stock Market performance with the rate: -24.4%.
Estimated limits based on current volatility of 4.1%: low 0.67$, high 0.73$
Factors to consider:
- Total employees count: 2 as of 2022
- Top business risk factors: Going concern doubt, Commercialization failure, Regulatory and compliance, Manufacturing capacity loss, Labor/talent shortage/retention
Short-term CTOR quotes
Long-term CTOR plot
Financial data
| YTD | 2023-09-30 | 2024-09-30 | 2025-09-30 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $12.12MM | $20.57MM | $23.52MM |
| Operating Income | $-12.12MM | $-20.57MM | $-23.52MM |
| Non-Operating Income | $0.00MM | $0.00MM | $-0.18MM |
| Interest Expense | $0.00MM | $0.00MM | $0.22MM |
| R&D Expense | $4.24MM | $4.93MM | $6.42MM |
| Income(Loss) | $-12.12MM | $-20.57MM | $-23.70MM |
| Taxes | $0.58MM | $0.58MM | $1.06MM |
| Net Income(Loss)* | $-12.70MM | $-21.15MM | $-24.76MM |
| Stockholders Equity | $25.54MM | $46.14MM | $44.87MM |
| Inventory | $0.00MM | $8.27MM | $22.29MM |
| Assets | $47.73MM | $84.37MM | $100.94MM |
| Operating Cash Flow | $-0.60MM | $0.13MM | $-5.49MM |
| Capital expenditure | $0.00MM | $0.00MM | $0.00MM |
| Investing Cash Flow | $-1.32MM | $-5.00MM | $-5.75MM |
| Financing Cash Flow | $1.66MM | $4.87MM | $15.17MM |
| Earnings Per Share** | $-0.14 | $-0.30 | $-0.34 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.